Invention Grant
US09012151B2 Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
有权
使用前肾上腺髓质素的后期心肌梗死患者的不良事件的诊断方法和风险分层
- Patent Title: Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin
- Patent Title (中): 使用前肾上腺髓质素的后期心肌梗死患者的不良事件的诊断方法和风险分层
-
Application No.: US11937061Application Date: 2007-11-08
-
Publication No.: US09012151B2Publication Date: 2015-04-21
- Inventor: Leong Loke Ng , Andreas Bergmann , Joachim Struck , Nils Morgenthaler , Jana Papassotiriou
- Applicant: Leong Loke Ng , Andreas Bergmann , Joachim Struck , Nils Morgenthaler , Jana Papassotiriou
- Applicant Address: DE Hennigsdorf
- Assignee: B.R.A.H.M.S. GmbH
- Current Assignee: B.R.A.H.M.S. GmbH
- Current Assignee Address: DE Hennigsdorf
- Agency: Novak Druce Connolly Bove + Quigg LLP
- Main IPC: G01N33/53
- IPC: G01N33/53 ; A61K39/00 ; A61K39/395 ; G01N33/563 ; A61K38/00 ; G01N33/68 ; G01N33/74
Abstract:
The invention provides methods for the diagnosis and risk stratification of adverse events in post-myocardial infarction patients by means of proADM, whereby a determination of the marker pro-adrenomedullin or partial sequence or a fragment thereof or contained in a marker combination (panel, cluster) is carried out on a post-myocardial infarction patient. The invention also provides a diagnostic device and a kit for the performance of the method of the method of the invention.
Public/Granted literature
Information query
IPC分类:
